Concert Genetics Registration- Medica

Beginning December 1, 2022, Medica will implement a new payment policy for genetic and molecular testing. All providers billing for genetic and molecular testing services included in the policy must adhere to the coding recommendations in the Concert Genetics portal.

Tests included:

  • Molecular pathology (81105-81479)
  • Genomic Sequencing Procedures and Other Molecular Multianalyte Assays (81410-81471)
  • Multianalyte Assays with Algorithmic Analyses (81490-81599)
  • Proprietary Laboratory Analyses (PLA) Codes

How to Register

Please fill out the form on this page. Within two business days, Concert Genetics will send a Welcome Packet that will include instructions on how to:

  • Create an account
  • Ensure your test catalog is accurate and up to date
  • Complete the Quality Questionnaire
  • View the Concert Genetics coding recommendations
  • Access the Concert GTUs

In addition, you will also gain access to:

  • FAQs
  • Training videos
  • Concert Genetics Coding Engine Whitepaper

Submit this form to begin the process

More about Concert

Concert (formerly NextGxDx) was founded in 2010 to bring transparency, efficiency, and value to the complex genetic testing market. Since then, the company has grown to offer the definitive payment accuracy platform for precision health services, including genetic testing, infectious disease, and other diagnostics.  

Today, Concert combines proprietary data on the U.S. clinical laboratory testing market, market-leading clinical and coding expertise, and advanced technology to support test ordering, resulting, coding, coverage, claim editing, and payment integrity. 

Health plans, health systems, laboratories, and an extensive network of partner organizations trust Concert to provide the content, technology, and integration capabilities to deliver precision health data integration and payment accuracy directly into the systems of record, ultimately enabling consumers cost-effective access to the latest in precision care.